Effect of Granulocyte Colony-stimulating Factor (G-CSF) in Functional Outcome of Acute Spinal Cord Injury Patients: A Single-blinded Randomized Controlled Trial

Overview

Journal J Orthop

Specialty Orthopedics

Date 2024 Dec 18

PMID 39691645

Authors

Prabu Mounissamy

A C Premraj

Sushma Chanadrashekar

Naveen Jeyaraman

Swaminathan Ramasubramanian

Madhan Jeyaraman

Affiliations

Soon will be listed here.

Abstract

Background: Spinal Cord Injury (SCI) is a major public health issue causing significant disability and economic burden. Current treatments primarily focus on mitigating secondary injury, with limited effective therapies available. This study explores the efficacy of the Granulocyte Colony-Stimulating Factor (G-CSF) in improving functional outcomes in acute SCI patients.

Materials And Methods: This single-blinded randomized control trial was conducted at JIPMER's orthopedic department. Patients with acute spinal cord injury (SCI) were enrolled based on specific inclusion and exclusion criteria. Participants were divided into two groups: Group A (n = 16) received a G-CSF injection whereas Group B (n = 18) received a placebo (normal saline) injection. The primary evaluation was based on the changes in the ASIA impairment scale at 1-, 3-, and 6-months post-injury.

Results: The study involved 34 participants, predominantly male. Initial assessments showed significant differences in ASIA scores between the groups. Group A demonstrated marked improvement in neurological status at 1, 3, and 6 months post-treatment compared to Group B. The frequency of adverse events was comparable between the two groups.

Conclusion: G-CSF showed significant improvement in ASIA scores at various time points post-administration compared to placebo. These findings suggest G-CSF as a potential therapeutic agent in acute SCI treatment. However, due to the small sample size, further research is necessary to confirm these results.

References

Solaroglu I, Cahill J, Jadhav V, Zhang J . A novel neuroprotectant granulocyte-colony stimulating factor. Stroke. 2006; 37(4):1123-8. DOI: 10.1161/01.STR.0000208205.26253.96. View

Solaroglu I, Tsubokawa T, Cahill J, Zhang J . Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience. 2006; 143(4):965-74. PMC: 1820637. DOI: 10.1016/j.neuroscience.2006.09.014. View

Goenka L, Uppugunduri Satyanarayana C, Kumar S S, George M . Neuroprotective agents in Acute Ischemic Stroke-A Reality Check. Biomed Pharmacother. 2018; 109:2539-2547. DOI: 10.1016/j.biopha.2018.11.041. View

Koda M, Hanaoka H, Fujii Y, Hanawa M, Kawasaki Y, Ozawa Y . Randomized trial of granulocyte colony-stimulating factor for spinal cord injury. Brain. 2021; 144(3):789-799. PMC: 8041047. DOI: 10.1093/brain/awaa466. View

Pierce H, Zhang D, Magnon C, Lucas D, Christin J, Huggins M . Cholinergic Signals from the CNS Regulate G-CSF-Mediated HSC Mobilization from Bone Marrow via a Glucocorticoid Signaling Relay. Cell Stem Cell. 2017; 20(5):648-658.e4. PMC: 5467872. DOI: 10.1016/j.stem.2017.01.002. View

Ding W, Hu S, Wang P, Kang H, Peng R, Dong Y . Spinal Cord Injury: The Global Incidence, Prevalence, and Disability From the Global Burden of Disease Study 2019. Spine (Phila Pa 1976). 2022; 47(21):1532-1540. PMC: 9554757. DOI: 10.1097/BRS.0000000000004417. View

Huang X, Liu Y, Bai S, Peng L, Zhang B, Lu H . Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trial. PLoS One. 2017; 12(4):e0175774. PMC: 5391086. DOI: 10.1371/journal.pone.0175774. View

Alizadeh A, Dyck S, Karimi-Abdolrezaee S . Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms. Front Neurol. 2019; 10:282. PMC: 6439316. DOI: 10.3389/fneur.2019.00282. View

Sultan I, Lamba N, Liew A, Doung P, Tewarie I, Amamoo J . The safety and efficacy of steroid treatment for acute spinal cord injury: A Systematic Review and meta-analysis. Heliyon. 2020; 6(2):e03414. PMC: 7033344. DOI: 10.1016/j.heliyon.2020.e03414. View

10.

Dumbuya J, Chen L, Shu S, Ma L, Luo W, Li F . G-CSF attenuates neuroinflammation and neuronal apoptosis via the mTOR/p70SK6 signaling pathway in neonatal Hypoxia-Ischemia rat model. Brain Res. 2020; 1739:146817. DOI: 10.1016/j.brainres.2020.146817. View

11.

Chikuda H, Yasunaga H, Takeshita K, Horiguchi H, Kawaguchi H, Ohe K . Mortality and morbidity after high-dose methylprednisolone treatment in patients with acute cervical spinal cord injury: a propensity-matched analysis using a nationwide administrative database. Emerg Med J. 2013; 31(3):201-6. PMC: 3932981. DOI: 10.1136/emermed-2012-202058. View

12.

Zou H, Guo S, Zhu L, Xu X, Liu J . Methylprednisolone Induces Neuro-Protective Effects via the Inhibition of A1 Astrocyte Activation in Traumatic Spinal Cord Injury Mouse Models. Front Neurosci. 2021; 15:628917. PMC: 8200570. DOI: 10.3389/fnins.2021.628917. View

13.

Takahashi H, Yamazaki M, Okawa A, Sakuma T, Kato K, Hashimoto M . Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial. Eur Spine J. 2012; 21(12):2580-7. PMC: 3508205. DOI: 10.1007/s00586-012-2213-3. View

14.

Lapidari P, Vaz-Luis I, Di Meglio A . Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review. Crit Rev Oncol Hematol. 2020; 157:103193. DOI: 10.1016/j.critrevonc.2020.103193. View

15.

Derakhshanrad N, Saberi H, Yekaninejad M, Eskandari G, Mardani A, Rahdari F . Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study. Cell Transplant. 2013; 22 Suppl 1:S139-46. DOI: 10.3727/096368913X672109. View

16.

Aschauer-Wallner S, Leis S, Bogdahn U, Johannesen S, Couillard-Despres S, Aigner L . Granulocyte colony-stimulating factor in traumatic spinal cord injury. Drug Discov Today. 2021; 26(7):1642-1655. DOI: 10.1016/j.drudis.2021.03.014. View

17.

Tao J, Fan X, Zhou J, Huo L, Mo Y, Bai H . Granulocyte colony-stimulating factor effects on neurological and motor function in animals with spinal cord injury: a systematic review and meta-analysis. Front Neurosci. 2023; 17:1168764. PMC: 10338098. DOI: 10.3389/fnins.2023.1168764. View

18.

Modi J, Menzie-Suderam J, Xu H, Trujillo P, Medley K, Marshall M . Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model. J Biomed Sci. 2020; 27(1):19. PMC: 6943893. DOI: 10.1186/s12929-019-0597-7. View

19.

Gascon P, Awada A, Karihtala P, Lorenzen S, Minichsdorfer C . Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment : An expert view. Wien Klin Wochenschr. 2023; 136(11-12):362-368. PMC: 11156747. DOI: 10.1007/s00508-023-02300-6. View

20.

Shyu W, Lin S, Lee C, Liu D, Li H . Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ. 2006; 174(7):927-33. PMC: 1405861. DOI: 10.1503/cmaj.051322. View